E2F3 and Familial prostate cancer: Furthermore, high E2F3 expression could reverse the regulatory effects of miR-194 mimics on DU145 cells, while E2F3 inhibition could eliminate the regulatory function of miR-194 inhibitors, suggesting that miR-194 could modulate prostate cancer cells via targeting E2F3.